Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion
Over the past few years, Insmed has garnered attention for its pipeline candidate and bronchiectasis treatment, brensocatib.
Archives for May 13, 2024
Regeneron gene therapy restores hearing in profoundly deaf child
Regeneron Pharmaceuticals’ gene therapy for otoferlin-related hearing loss, a genetic cause of deafness, has restored hearing to normal levels in one deaf child within just 24 weeks.
Circio debuts proof-of-concept for circVec gene therapy at ASGCT 2024
Circio, a biotech firm specializing in circular RNA-based gene therapy, has unveiled two posters showcasing in vivo proof-of-concept for its circVec platform at ASGCT 2024.